nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—Photosensitivity—Vemurafenib—skin cancer	0.0196	0.0197	CcSEcCtD
Dimenhydrinate—Chest tightness—Docetaxel—skin cancer	0.0172	0.0172	CcSEcCtD
Dimenhydrinate—Nasal congestion—Imiquimod—skin cancer	0.0161	0.0162	CcSEcCtD
Dimenhydrinate—Irritability—Imiquimod—skin cancer	0.014	0.014	CcSEcCtD
Dimenhydrinate—Urinary retention—Imiquimod—skin cancer	0.014	0.014	CcSEcCtD
Dimenhydrinate—Wheezing—Bleomycin—skin cancer	0.014	0.014	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Vemurafenib—skin cancer	0.0136	0.0136	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Vemurafenib—skin cancer	0.013	0.013	CcSEcCtD
Dimenhydrinate—Sweating increased—Imiquimod—skin cancer	0.0124	0.0124	CcSEcCtD
Dimenhydrinate—Dyspepsia—Vismodegib—skin cancer	0.0121	0.0121	CcSEcCtD
Dimenhydrinate—Decreased appetite—Vismodegib—skin cancer	0.0119	0.0119	CcSEcCtD
Dimenhydrinate—Dysuria—Imiquimod—skin cancer	0.0119	0.0119	CcSEcCtD
Dimenhydrinate—Fatigue—Vismodegib—skin cancer	0.0118	0.0118	CcSEcCtD
Dimenhydrinate—Constipation—Vismodegib—skin cancer	0.0117	0.0117	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Imiquimod—skin cancer	0.0116	0.0116	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Imiquimod—skin cancer	0.0111	0.0111	CcSEcCtD
Dimenhydrinate—Neuritis—Docetaxel—skin cancer	0.0108	0.0108	CcSEcCtD
Dimenhydrinate—Chills—Vemurafenib—skin cancer	0.0107	0.0107	CcSEcCtD
Dimenhydrinate—Asthenia—Vismodegib—skin cancer	0.00983	0.00985	CcSEcCtD
Dimenhydrinate—Nasal congestion—Temozolomide—skin cancer	0.00967	0.00968	CcSEcCtD
Dimenhydrinate—Euphoric mood—Fluorouracil—skin cancer	0.0096	0.00962	CcSEcCtD
Dimenhydrinate—Tinnitus—Imiquimod—skin cancer	0.00948	0.00949	CcSEcCtD
Dimenhydrinate—Diarrhoea—Vismodegib—skin cancer	0.00938	0.00939	CcSEcCtD
Dimenhydrinate—Photosensitivity—Fluorouracil—skin cancer	0.00924	0.00926	CcSEcCtD
Dimenhydrinate—Chills—Imiquimod—skin cancer	0.00912	0.00914	CcSEcCtD
Dimenhydrinate—Chest discomfort—Docetaxel—skin cancer	0.00912	0.00913	CcSEcCtD
Dimenhydrinate—Diplopia—Temozolomide—skin cancer	0.00881	0.00882	CcSEcCtD
Dimenhydrinate—Vomiting—Vismodegib—skin cancer	0.00871	0.00873	CcSEcCtD
Dimenhydrinate—Rash—Vismodegib—skin cancer	0.00864	0.00866	CcSEcCtD
Dimenhydrinate—Dermatitis—Vismodegib—skin cancer	0.00863	0.00865	CcSEcCtD
Dimenhydrinate—Nausea—Vismodegib—skin cancer	0.00814	0.00816	CcSEcCtD
Dimenhydrinate—Agitation—Imiquimod—skin cancer	0.00813	0.00815	CcSEcCtD
Dimenhydrinate—Hypotension—Vemurafenib—skin cancer	0.00791	0.00793	CcSEcCtD
Dimenhydrinate—Palpitations—Imiquimod—skin cancer	0.00782	0.00783	CcSEcCtD
Dimenhydrinate—Irritability—Fluorouracil—skin cancer	0.00774	0.00776	CcSEcCtD
Dimenhydrinate—Convulsion—Imiquimod—skin cancer	0.00767	0.00768	CcSEcCtD
Dimenhydrinate—Sweating increased—Temozolomide—skin cancer	0.00741	0.00743	CcSEcCtD
Dimenhydrinate—Dry mouth—Imiquimod—skin cancer	0.00737	0.00738	CcSEcCtD
Dimenhydrinate—Decreased appetite—Vemurafenib—skin cancer	0.00736	0.00737	CcSEcCtD
Dimenhydrinate—Fatigue—Vemurafenib—skin cancer	0.0073	0.00731	CcSEcCtD
Dimenhydrinate—Constipation—Vemurafenib—skin cancer	0.00724	0.00725	CcSEcCtD
Dimenhydrinate—Dysuria—Temozolomide—skin cancer	0.00712	0.00713	CcSEcCtD
Dimenhydrinate—Tachycardia—Imiquimod—skin cancer	0.00705	0.00706	CcSEcCtD
Dimenhydrinate—Pollakiuria—Temozolomide—skin cancer	0.00703	0.00704	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Dactinomycin—skin cancer	0.007	0.00701	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Imiquimod—skin cancer	0.00698	0.00699	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Temozolomide—skin cancer	0.00695	0.00696	CcSEcCtD
Dimenhydrinate—Anorexia—Imiquimod—skin cancer	0.00688	0.0069	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Temozolomide—skin cancer	0.00665	0.00666	CcSEcCtD
Dimenhydrinate—Insomnia—Imiquimod—skin cancer	0.00653	0.00654	CcSEcCtD
Dimenhydrinate—Paraesthesia—Imiquimod—skin cancer	0.00648	0.0065	CcSEcCtD
Dimenhydrinate—Chills—Bleomycin—skin cancer	0.00648	0.00649	CcSEcCtD
Dimenhydrinate—Somnolence—Imiquimod—skin cancer	0.00642	0.00643	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Fluorouracil—skin cancer	0.0064	0.00641	CcSEcCtD
Dimenhydrinate—Dyspepsia—Imiquimod—skin cancer	0.00636	0.00637	CcSEcCtD
Dimenhydrinate—Decreased appetite—Imiquimod—skin cancer	0.00628	0.00629	CcSEcCtD
Dimenhydrinate—Fatigue—Imiquimod—skin cancer	0.00623	0.00624	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Fluorouracil—skin cancer	0.00613	0.00614	CcSEcCtD
Dimenhydrinate—Asthenia—Vemurafenib—skin cancer	0.00608	0.00609	CcSEcCtD
Dimenhydrinate—Chills—Dactinomycin—skin cancer	0.00604	0.00605	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Imiquimod—skin cancer	0.00595	0.00596	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Fluorouracil—skin cancer	0.00583	0.00584	CcSEcCtD
Dimenhydrinate—Diarrhoea—Vemurafenib—skin cancer	0.00579	0.0058	CcSEcCtD
Dimenhydrinate—Urticaria—Imiquimod—skin cancer	0.00574	0.00575	CcSEcCtD
Dimenhydrinate—Tinnitus—Temozolomide—skin cancer	0.00568	0.00569	CcSEcCtD
Dimenhydrinate—Dizziness—Vemurafenib—skin cancer	0.0056	0.00561	CcSEcCtD
Dimenhydrinate—Chills—Temozolomide—skin cancer	0.00547	0.00548	CcSEcCtD
Dimenhydrinate—Vomiting—Vemurafenib—skin cancer	0.00538	0.00539	CcSEcCtD
Dimenhydrinate—Rash—Vemurafenib—skin cancer	0.00534	0.00535	CcSEcCtD
Dimenhydrinate—Dermatitis—Vemurafenib—skin cancer	0.00533	0.00534	CcSEcCtD
Dimenhydrinate—Headache—Vemurafenib—skin cancer	0.0053	0.00531	CcSEcCtD
Dimenhydrinate—Asthenia—Imiquimod—skin cancer	0.00518	0.00519	CcSEcCtD
Dimenhydrinate—Confusional state—Bleomycin—skin cancer	0.00517	0.00518	CcSEcCtD
Dimenhydrinate—Nausea—Vemurafenib—skin cancer	0.00503	0.00504	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Bleomycin—skin cancer	0.00502	0.00503	CcSEcCtD
Dimenhydrinate—Vision blurred—Temozolomide—skin cancer	0.005	0.00501	CcSEcCtD
Dimenhydrinate—Tremor—Temozolomide—skin cancer	0.00497	0.00498	CcSEcCtD
Dimenhydrinate—Diarrhoea—Imiquimod—skin cancer	0.00494	0.00495	CcSEcCtD
Dimenhydrinate—Anorexia—Bleomycin—skin cancer	0.00489	0.0049	CcSEcCtD
Dimenhydrinate—Agitation—Temozolomide—skin cancer	0.00487	0.00488	CcSEcCtD
Dimenhydrinate—Hypotension—Bleomycin—skin cancer	0.00479	0.0048	CcSEcCtD
Dimenhydrinate—Dizziness—Imiquimod—skin cancer	0.00478	0.00478	CcSEcCtD
Dimenhydrinate—Vertigo—Temozolomide—skin cancer	0.00476	0.00477	CcSEcCtD
Dimenhydrinate—Palpitations—Temozolomide—skin cancer	0.00469	0.00469	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Dactinomycin—skin cancer	0.00468	0.00469	CcSEcCtD
Dimenhydrinate—Paraesthesia—Bleomycin—skin cancer	0.00461	0.00461	CcSEcCtD
Dimenhydrinate—Vision blurred—Fluorouracil—skin cancer	0.0046	0.00461	CcSEcCtD
Dimenhydrinate—Convulsion—Temozolomide—skin cancer	0.00459	0.0046	CcSEcCtD
Dimenhydrinate—Vomiting—Imiquimod—skin cancer	0.00459	0.0046	CcSEcCtD
Dimenhydrinate—Anorexia—Dactinomycin—skin cancer	0.00456	0.00457	CcSEcCtD
Dimenhydrinate—Rash—Imiquimod—skin cancer	0.00455	0.00456	CcSEcCtD
Dimenhydrinate—Dermatitis—Imiquimod—skin cancer	0.00455	0.00456	CcSEcCtD
Dimenhydrinate—Headache—Imiquimod—skin cancer	0.00452	0.00453	CcSEcCtD
Dimenhydrinate—Decreased appetite—Bleomycin—skin cancer	0.00446	0.00447	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Docetaxel—skin cancer	0.00442	0.00443	CcSEcCtD
Dimenhydrinate—Dry mouth—Temozolomide—skin cancer	0.00442	0.00442	CcSEcCtD
Dimenhydrinate—Confusional state—Temozolomide—skin cancer	0.00436	0.00437	CcSEcCtD
Dimenhydrinate—Nausea—Imiquimod—skin cancer	0.00429	0.0043	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Temozolomide—skin cancer	0.00424	0.00424	CcSEcCtD
Dimenhydrinate—Convulsion—Fluorouracil—skin cancer	0.00423	0.00424	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Bleomycin—skin cancer	0.00423	0.00424	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Docetaxel—skin cancer	0.00421	0.00422	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Temozolomide—skin cancer	0.00418	0.00419	CcSEcCtD
Dimenhydrinate—Decreased appetite—Dactinomycin—skin cancer	0.00416	0.00417	CcSEcCtD
Dimenhydrinate—Fatigue—Dactinomycin—skin cancer	0.00413	0.00413	CcSEcCtD
Dimenhydrinate—Anorexia—Temozolomide—skin cancer	0.00413	0.00413	CcSEcCtD
Dimenhydrinate—Urticaria—Bleomycin—skin cancer	0.00408	0.00408	CcSEcCtD
Dimenhydrinate—Confusional state—Fluorouracil—skin cancer	0.00402	0.00403	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Dactinomycin—skin cancer	0.00394	0.00395	CcSEcCtD
Dimenhydrinate—Insomnia—Temozolomide—skin cancer	0.00391	0.00392	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Fluorouracil—skin cancer	0.0039	0.00391	CcSEcCtD
Dimenhydrinate—Tachycardia—Fluorouracil—skin cancer	0.00389	0.0039	CcSEcCtD
Dimenhydrinate—Paraesthesia—Temozolomide—skin cancer	0.00389	0.00389	CcSEcCtD
Dimenhydrinate—Somnolence—Temozolomide—skin cancer	0.00385	0.00385	CcSEcCtD
Dimenhydrinate—Dyspepsia—Temozolomide—skin cancer	0.00381	0.00382	CcSEcCtD
Dimenhydrinate—Anorexia—Fluorouracil—skin cancer	0.0038	0.00381	CcSEcCtD
Dimenhydrinate—Decreased appetite—Temozolomide—skin cancer	0.00376	0.00377	CcSEcCtD
Dimenhydrinate—Fatigue—Temozolomide—skin cancer	0.00373	0.00374	CcSEcCtD
Dimenhydrinate—Hypotension—Fluorouracil—skin cancer	0.00373	0.00373	CcSEcCtD
Dimenhydrinate—Constipation—Temozolomide—skin cancer	0.0037	0.00371	CcSEcCtD
Dimenhydrinate—Asthenia—Bleomycin—skin cancer	0.00368	0.00369	CcSEcCtD
Dimenhydrinate—Chills—Docetaxel—skin cancer	0.00363	0.00364	CcSEcCtD
Dimenhydrinate—Insomnia—Fluorouracil—skin cancer	0.00361	0.00361	CcSEcCtD
Dimenhydrinate—Paraesthesia—Fluorouracil—skin cancer	0.00358	0.00359	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Temozolomide—skin cancer	0.00357	0.00357	CcSEcCtD
Dimenhydrinate—Somnolence—Fluorouracil—skin cancer	0.00354	0.00355	CcSEcCtD
Dimenhydrinate—Dyspepsia—Fluorouracil—skin cancer	0.00351	0.00352	CcSEcCtD
Dimenhydrinate—Decreased appetite—Fluorouracil—skin cancer	0.00347	0.00347	CcSEcCtD
Dimenhydrinate—Urticaria—Temozolomide—skin cancer	0.00344	0.00344	CcSEcCtD
Dimenhydrinate—Asthenia—Dactinomycin—skin cancer	0.00343	0.00344	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Fluorouracil—skin cancer	0.00329	0.00329	CcSEcCtD
Dimenhydrinate—Diarrhoea—Dactinomycin—skin cancer	0.00327	0.00328	CcSEcCtD
Dimenhydrinate—Vomiting—Bleomycin—skin cancer	0.00326	0.00327	CcSEcCtD
Dimenhydrinate—Rash—Bleomycin—skin cancer	0.00323	0.00324	CcSEcCtD
Dimenhydrinate—Dermatitis—Bleomycin—skin cancer	0.00323	0.00324	CcSEcCtD
Dimenhydrinate—Urticaria—Fluorouracil—skin cancer	0.00317	0.00317	CcSEcCtD
Dimenhydrinate—Palpitations—Docetaxel—skin cancer	0.00312	0.00312	CcSEcCtD
Dimenhydrinate—Asthenia—Temozolomide—skin cancer	0.0031	0.00311	CcSEcCtD
Dimenhydrinate—Convulsion—Docetaxel—skin cancer	0.00306	0.00306	CcSEcCtD
Dimenhydrinate—Nausea—Bleomycin—skin cancer	0.00305	0.00305	CcSEcCtD
Dimenhydrinate—Vomiting—Dactinomycin—skin cancer	0.00304	0.00305	CcSEcCtD
Dimenhydrinate—Rash—Dactinomycin—skin cancer	0.00302	0.00302	CcSEcCtD
Dimenhydrinate—Diarrhoea—Temozolomide—skin cancer	0.00296	0.00297	CcSEcCtD
Dimenhydrinate—Dry mouth—Docetaxel—skin cancer	0.00294	0.00294	CcSEcCtD
Dimenhydrinate—Confusional state—Docetaxel—skin cancer	0.0029	0.00291	CcSEcCtD
Dimenhydrinate—Dizziness—Temozolomide—skin cancer	0.00286	0.00287	CcSEcCtD
Dimenhydrinate—Nausea—Dactinomycin—skin cancer	0.00284	0.00285	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Docetaxel—skin cancer	0.00282	0.00282	CcSEcCtD
Dimenhydrinate—Tachycardia—Docetaxel—skin cancer	0.00281	0.00281	CcSEcCtD
Dimenhydrinate—Vomiting—Temozolomide—skin cancer	0.00275	0.00276	CcSEcCtD
Dimenhydrinate—Anorexia—Docetaxel—skin cancer	0.00274	0.00275	CcSEcCtD
Dimenhydrinate—Rash—Temozolomide—skin cancer	0.00273	0.00273	CcSEcCtD
Dimenhydrinate—Diarrhoea—Fluorouracil—skin cancer	0.00273	0.00273	CcSEcCtD
Dimenhydrinate—Dermatitis—Temozolomide—skin cancer	0.00273	0.00273	CcSEcCtD
Dimenhydrinate—Headache—Temozolomide—skin cancer	0.00271	0.00272	CcSEcCtD
Dimenhydrinate—Hypotension—Docetaxel—skin cancer	0.00269	0.00269	CcSEcCtD
Dimenhydrinate—Dizziness—Fluorouracil—skin cancer	0.00264	0.00264	CcSEcCtD
Dimenhydrinate—Insomnia—Docetaxel—skin cancer	0.0026	0.00261	CcSEcCtD
Dimenhydrinate—Paraesthesia—Docetaxel—skin cancer	0.00258	0.00259	CcSEcCtD
Dimenhydrinate—Nausea—Temozolomide—skin cancer	0.00257	0.00258	CcSEcCtD
Dimenhydrinate—Somnolence—Docetaxel—skin cancer	0.00256	0.00256	CcSEcCtD
Dimenhydrinate—Vomiting—Fluorouracil—skin cancer	0.00254	0.00254	CcSEcCtD
Dimenhydrinate—Dyspepsia—Docetaxel—skin cancer	0.00253	0.00254	CcSEcCtD
Dimenhydrinate—Rash—Fluorouracil—skin cancer	0.00251	0.00252	CcSEcCtD
Dimenhydrinate—Dermatitis—Fluorouracil—skin cancer	0.00251	0.00252	CcSEcCtD
Dimenhydrinate—Decreased appetite—Docetaxel—skin cancer	0.0025	0.00251	CcSEcCtD
Dimenhydrinate—Headache—Fluorouracil—skin cancer	0.0025	0.0025	CcSEcCtD
Dimenhydrinate—Fatigue—Docetaxel—skin cancer	0.00248	0.00249	CcSEcCtD
Dimenhydrinate—Constipation—Docetaxel—skin cancer	0.00246	0.00247	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Docetaxel—skin cancer	0.00237	0.00238	CcSEcCtD
Dimenhydrinate—Nausea—Fluorouracil—skin cancer	0.00237	0.00237	CcSEcCtD
Dimenhydrinate—Asthenia—Docetaxel—skin cancer	0.00206	0.00207	CcSEcCtD
Dimenhydrinate—Diarrhoea—Docetaxel—skin cancer	0.00197	0.00197	CcSEcCtD
Dimenhydrinate—Dizziness—Docetaxel—skin cancer	0.0019	0.00191	CcSEcCtD
Dimenhydrinate—Vomiting—Docetaxel—skin cancer	0.00183	0.00183	CcSEcCtD
Dimenhydrinate—Rash—Docetaxel—skin cancer	0.00181	0.00182	CcSEcCtD
Dimenhydrinate—Dermatitis—Docetaxel—skin cancer	0.00181	0.00182	CcSEcCtD
Dimenhydrinate—Headache—Docetaxel—skin cancer	0.0018	0.00181	CcSEcCtD
Dimenhydrinate—Orphenadrine—SCN10A—skin cancer	0.00173	1	CrCbGaD
Dimenhydrinate—Nausea—Docetaxel—skin cancer	0.00171	0.00171	CcSEcCtD
